Skip to main content
logo
Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0910
+0.0020 (2.25%)
Jun 18, 2026, 6:07 PM HKT

Revenue by Segment

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Chinese Medicine Business (Excluding Medical and Healthcare Services)
59.26M29.49M51.80M-107.55M
Chinese Medicine Business (Excluding Medical and Healthcare Services) Growth
100.92%-43.06%---4.50%
Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business)
249.28M285.71M471.20M462.64M396.50M
Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business) Growth
-12.75%-39.36%1.85%16.68%10.74%
Medical and Healthcare Services
22.23M19.05M13.04M14.97M7.35M
Medical and Healthcare Services Growth
16.67%46.12%-12.90%103.62%57.02%
Elimination of Intersegment Sales
-7.82M-4.32M-3.94M-5.14M-1.45M
Chinese Medical Business
---74.23M-
Total
322.95M329.94M532.09M546.69M509.96M
Total Growth
-2.12%-37.99%-2.67%7.20%7.51%

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Chinese Mainland
315.14M320.99M524.13M538.11M505.95M
Chinese Mainland Growth
-1.82%-38.76%-2.60%6.36%7.11%
Hong Kong
6.39M7.74M6.47M7.71M3.64M
Hong Kong Growth
-17.54%19.62%-16.02%111.99%131.65%
Australia
1.42M1.20M1.49M880.00K366.00K
Australia Growth
18.05%-19.33%69.32%140.44%-2.22%
Total
322.95M329.94M532.09M546.69M509.96M
Total Growth
-2.12%-37.99%-2.67%7.20%7.51%